Cbd Biosynthesis

CBD biosynthesis refers to the biochemical pathway through which cannabis plants produce cannabidiol (CBD), one of the two major cannabinoids. This process is governed by specific genetic sequences, particularly the CBDA synthase enzyme, which converts cannabigerolic acid (CBGA) into cannabidiolic acid (CBDA)—the precursor to CBD. Plants expressing active CBD biosynthesis pathways are commonly selected in modern breeding programs seeking CBD-dominant or CBD-rich phenotypes. The expression of CBD biosynthesis is inherited and can be reliably tracked across generations, making it a key target for stabilizing high-CBD cultivars. Understanding this genetic pathway helps breeders distinguish between true CBD-producing lineages and plants that may only express trace amounts.

Breeders working in the CBD-dominant category directly select for plants demonstrating consistent CBDA/CBD expression across controlled environments. Lineage records frequently report that stable CBD biosynthesis requires careful phenotyping and backcrossing to maintain the genetic markers controlling this enzymatic function.